Tech Company Financing Transactions
Unnatural Products Funding Round
Unnatural Products closed a $45 million Series B funding round on 3/16/2026. Backers included The Venture Collective, ARTIS Ventures and Droia Ventures.
Transaction Overview
Company Name
Announced On
3/16/2026
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series B
Investors
The Venture Collective (Lead Investor) (Nicholas Shekerdemian)
Proceeds Purpose
The funding will support development of the company's proprietary drug discovery platform and advance its pipeline of macrocyclic peptide therapeutics designed to address historically difficult-to-drug or undruggable targets.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Santa Cruz, CA 95060
USA
Santa Cruz, CA 95060
USA
Phone
Undisclosed
Website
Email Address
Overview
A startup focused on the undruggable space of intracellular protein interactions using macrocycles, Unnatural Products, Inc. is headquartered in Santa Cruz, California.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Cameron Pye
Browse more venture capital transactions:
Prev: 3/16/2026: Zero RFI venture capital transaction
Next: 3/16/2026: WhiteBridge venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs